Company Overview
Health In Tech, Inc. functions as an insurance technology platform company, delivering specialized solutions such as reference-based pricing, group insurance captives, community health plans, and association health programs designed for small businesses. The firm also provides the enhance do it yourself benefit system (eDIYBS), which is a web-based SaaS quoting platform. This entity operates within the Technology sector, specifically classified under the Software - Application industry, positioning it as a provider of digital infrastructure for the insurance landscape. As of the latest reporting period, the company holds a market capitalization of $83.34M and generates annual revenue of $33.33M, while the specific employee count is not disclosed in available records. These financial dimensions suggest a mid-sized market presence where the relatively modest market cap compared to its revenue base indicates a company that may be priced with a premium reflecting its specific niche capabilities or growth expectations rather than broad-scale dominance.
Financial Health
The company reported revenue of $33.33M over the trailing twelve months, generating net income of $1.28M and an EBITDA of $2.43M during the same period. The significant gap between the $33.33M in revenue and the $1.28M in net income reveals a cost structure where operating expenses consume a substantial portion of top-line growth, resulting in an operating margin of -2.3%. Despite the negative operating margin, the company achieved a profit margin of 3.8%, indicating that non-operating factors or specific accounting adjustments contributed to the bottom line. However, the free cash flow stands at $-3,874,460, which signals that the company is currently burning cash and lacks immediate financial flexibility to fund expansion without external capital injections. The balance sheet shows $7.67M in cash holdings against $139,812 in debt, resulting in a debt-to-equity ratio of 0.82. While the company carries some leverage, the disparity between cash reserves and debt obligations suggests a relatively conservative stance on short-term solvency despite the operational cash burn. Liquidity is supported by a current ratio of 3.13, indicating that the firm possesses more than three times the current assets necessary to cover its current liabilities, providing a comfortable buffer for short-term obligations. Return on Equity stands at 8.4% and return on assets is 4.9%, metrics that suggest management is generating returns that exceed the cost of capital but are moderated by the company's asset base and equity structure.
Valuation Assessment
The trailing twelve-month P/E ratio is 69.50, whereas the forward P/E is significantly lower at 6.95, implying that the market expects earnings to expand substantially in the coming periods to justify the current high multiple. The price-to-book ratio is 3.48, indicating that the market values the company at a significant premium over its book value, likely reflecting intangible assets or growth potential that are not captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 2.50 and the EV/EBITDA of 21.46 provide different perspectives on value, suggesting that the company is valued highly relative to its sales generation but moderately relative to its earnings before interest, taxes, depreciation, and amortization. The stock has traded between a 52-week high of $4.02 and a 52-week low of $0.51, and without the current price explicitly listed in the facts, the valuation range is defined by this wide volatility band. The beta value is not available in the provided data, which prevents a direct comparison of price volatility relative to the broader market.
Growth & Income
Revenue growth over the past year stands at 53.1%, while earnings growth is not available for the trailing twelve months due to the specific earnings dynamics reported. The absence of reported earnings growth data prevents a direct comparison of earnings speed versus revenue expansion, though the high revenue growth suggests strong market traction in the insurance technology space. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm reinvests all of its generated earnings back into the business to fuel operations and growth rather than returning capital to shareholders. This non-dividend profile aligns with a growth-oriented strategy where cash is prioritized for internal development and expansion over income distribution. The overall growth and income profile is characterized by robust revenue expansion and a complete reinvestment of profits, supported by a cash-rich balance sheet but challenged by negative free cash flow.